Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder

The aim of this post-hoc analysis was to determine whether early symptom improvement with extended release quetiapine (quetiapine XR) may predict treatment outcome in patients with major depressive disorder. Data were from 6, double-blind, placebo-controlled studies of quetiapine XR (2 fixed-dose an...

Descripción completa

Detalles Bibliográficos
Autores principales: McIntyre, Roger S., Gorwood, Philip, Thase, Michael E., Liss, Charlie, Desai, Dhaval, Chen, Ji, Bauer, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898901/
https://www.ncbi.nlm.nih.gov/pubmed/26474010
http://dx.doi.org/10.1097/JCP.0000000000000416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898901/
https://www.ncbi.nlm.nih.gov/pubmed/26474010
http://dx.doi.org/10.1097/JCP.0000000000000416

Ejemplares similares